Literature DB >> 29578151

MiR-186 inhibits cell proliferation and invasion in human cutaneous malignant melanoma.

Bei-Bei Su1, Shu-Wei Zhou2, Cai-Bin Gan1, Xiao-Ning Zhang1.   

Abstract

AIMS: MicroRNA-186 (miR-186) has been shown to be involved in various types of cancer. The purpose of this study was to investigate the expression level and functional role of miR-186 in human cutaneous malignant melanoma cells. SUBJECTS AND METHODS: Expression of miR-186 was analyzed in human cutaneous malignant melanoma (CMM) cell lines SK-MEL-1, G-361, A375 and A875, and human normal epidermal melanocytes cell line HEMn-LP by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Additionally, the functional role of miR-186 on melanoma cells was investigated by transfection of miR-186 mimic followed by analyses of cell proliferation, apoptosis, and metastasis.
RESULTS: We found that the expression levels of miR-186 were decreased in CMM cell lines compared with normal epidermal melanocytes cell line. Moreover, overexpression of miR-186 inhibited cells proliferation through abrogating the G1-S transition, and reduced cells migration and invasion.
CONCLUSIONS: Our findings suggested that miR-186 exhibit an inhibitory effect on CMM cell proliferation, migration, and invasion; thus, may serve as a potential therapeutic target for human CMM intervention.

Entities:  

Keywords:  Cutaneous malignant melanoma; invasion; miR-186; proliferation

Mesh:

Substances:

Year:  2018        PMID: 29578151     DOI: 10.4103/0973-1482.157340

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  6 in total

1.  Overexpression of hsa-miR-186 induces chromosomal instability in arsenic-exposed human keratinocytes.

Authors:  Jiguo Wu; Ana P Ferragut Cardoso; Vanessa A R States; Laila Al-Eryani; Mark Doll; Sandra S Wise; Shesh N Rai; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-06       Impact factor: 4.219

2.  The lncRNA-DLEU2/miR-186-5p/PDK3 axis promotes the progress of glioma cells.

Authors:  Zuochang Xie; Xiaojian Li; Hua Chen; Ailiang Zeng; Yan Shi; Yong Tang
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

3.  MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2.

Authors:  Xiurong Lu; Xiao Song; Xiaohui Hao; Xiaoyu Liu; Xianyu Zhang; Na Yuan; Huan Ma; Zhilin Zhang
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 2.967

Review 4.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

Review 5.  Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View.

Authors:  Aigli Korfiati; Katerina Grafanaki; George C Kyriakopoulos; Ilias Skeparnias; Sophia Georgiou; George Sakellaropoulos; Constantinos Stathopoulos
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

Review 6.  Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms.

Authors:  Fei Liu; Shenglong Li
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.